Chronic interstitial lung disease in children

Matthias Griese

Source: Eur Respir Rev, 27 (147) 170100; 10.1183/16000617.0100-2017

Journal Issue: March

Disease area: Interstitial lung diseases, Paediatric lung diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Matthias Griese. Chronic interstitial lung disease in children. Eur Respir Rev, 27 (147) 170100; 10.1183/16000617.0100-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Chronic interstitial lung disease in children: diagnosis and treatment Source: International Congress 2016 – PG6 Lung fibrosis and sarcoidosis Year: 2016
Task force on chronic interstitial lung disease in immunocompetent children Source: Eur Respir J 2004; 24 : 686-697 Year: 2004
Acute exacerbations of interstitial lung disease Source: Eur Respir Monogr 2016; 74: 117-131 Year: 2016
The management of children with interstitial lung disease Source: International Congress 2018 – Difficult paediatric lung disease Year: 2018
Using the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2015 – IIPs: orphan Year: 2015
Chronic interstitial lung in children: diagnosis and treatment Source: International Congress 2015 – PG17 Lung fibrosis and sarcoidosis Year: 2015
Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013
Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016
Variation in mortality from interstitial lung disease by diagnosis Source: International Congress 2015 – IIPs: orphan Year: 2015
Acute exacerbations of progressive-fibrosing interstitial lung diseases Source: Eur Respir Rev, 27 (150) 180071; 10.1183/16000617.0071-2018 Year: 2018
Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019
Variability in expression of aquoporine 1 in chronic obstructive pulmonary disease and interstitial lung disease patients Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009
Interstitial lung disease caused by designer drugs Source: International Congress 2015 – A morphological view of chest pathology Year: 2015
Clinical experience with nintedanib for the treatment of IPF in 80 cases Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016
Does hypoxemia increases risks in hospitalized patients with diffuse interstitial lung disease? Source: International Congress 2014 – ILDs 6 Year: 2014
Senotherapies for chronic lung disease Source: ERS Lung Science Conference 2020 Year: 2020
Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013
The prognostic factor in patients with myositis-associated interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014